Skip to main content
Clinical Trials/ACTRN12612001041842
ACTRN12612001041842
Terminated
Phase 3

Cognitive Rehabilitation for Cancer Survivors with Perceived Cognitive Impairment

The University of Sydney0 sites65 target enrollmentSeptember 28, 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
The University of Sydney
Enrollment
65
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 28, 2012
End Date
February 11, 2022
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1Diagnosis of invasive solid tumour cancer for which definitive treatment was performed within the last 5 years
  • 2Completed at least 3 cycles of chemotherapy
  • 3Aged \>17 years
  • 4A NO” response recorded for the Single Item Cognitive Impairment Question
  • 5Speak fluent English and read to a year 8 standard.
  • 6Give written informed consent.
  • 7Chemotherapy, radiotherapy, immunotherapy (e.g. trastuzumab and/or lapatinib) received must have been completed at least 6 months prior to randomisation.
  • 8Hormonal treatment (including tamoxifen or an aromatase inhibitor) is permitted as long as treatment has been commenced at least 4 weeks prior to randomisation and is not likely to be ceased within 6 months of randomisation.

Exclusion Criteria

  • 1, ECOG Performance Status of \> 2
  • 2, Any evidence of extra\-nodal metastatic disease.
  • 3, Any major pre\-existing neurological condition, co\-morbidity, psychiatric history or substance abuse that could interfere with their ability to perform cognitive testing.
  • 4, Prior malignancy within the last 5 years (other than non\-melanomatous skin cancer or cervical cancer in\-situ) or previous chemotherapy other than adjuvant or neoadjuvant breast cancer treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials